By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Regen BioPharma  

4700 Spring Street
Suite 304
La Mesa  California  91942  U.S.A.
Phone: 619-702-1404 Fax: 619-330-2328


Company News
Regen BioPharma Announces Preferred Stock Dividend 2/25/2015 1:56:59 PM
Regen BioPharma Comments On Dcellvax Cancer IDO-Targeting Technology In Relation To Bristol-Myers Squibb (BMY)-Flexus Biosciences Announcement 2/25/2015 1:54:57 PM
Regen BioPharma Expands Management Team With The Addition Of New CFO Todd Caven 2/17/2015 10:02:54 AM
Regen BioPharma Provides Update On Company's Progress And Areas Of Specialization For 2015 1/15/2015 9:43:11 AM
Regen BioPharma Identifies Second Generation Gene Silencing Candidates For Blocking Cancer Stem Cell Gene Target 1/9/2015 9:09:31 AM
Regen BioPharma Presented Novel Therapeutic Target For Leukemia And Myelodysplastic Syndrome At The American Society of Hematology Annual Meeting 12/12/2014 11:27:06 AM
Regen BioPharma Scheduled To Make Presentation At American Society of Hematology's 56th Annual Meeting In San Francisco December 6th - 9th 12/3/2014 2:17:35 PM
Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property 11/25/2014 9:12:10 AM
FDA Issues IND Number For Regen BioPharma 's dCellVax Therapeutic Application, A Proposed Treatment For Breast Cancer 11/4/2014 11:02:15 AM
Regen BioPharma 's Chief Scientific Officer Examines Potential Role Of Immunotherapeutic Treatment For Ebola In Conjunction With Other Current Therapies 10/29/2014 11:54:17 AM